Volume 24, Number 6—June 2018
CME ACTIVITY - Research
Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission
|Risk group||Score||No. NE patients||Observed severe NE, no. (%)|
*Data were missing for 11 patients, who were excluded in this analysis. However, similar results for observed severe NE were obtained when assuming a score of zero for missing data: low (4.7%, 3/64), intermediate (20.1%, 18/87), and high (44.4%, 24/54). The leukocyte count and platelet count at admission were missing from the 1 additional patient with severe NE categorized as low risk in this analysis. NE, nephropathia epidemica.